Update on ICH E6 (R2) Guideline for GCP
The ICH E6 R2 Addendum is starting to have a significant, positive impact on clinical trial design – offering a real opportunity to inject efficiencies into clinical research and development.
A Revolutionary Cure for RBM and Centralized Monitoring
In the clinical trials industry there is a tendency to watch and wait, which has been the case with RBM.
